Progress toward Better Treatment of Lupus
- PMID: 36069878
- DOI: 10.1056/NEJMe2208772
Progress toward Better Treatment of Lupus
Comment on
-
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.N Engl J Med. 2022 Sep 8;387(10):894-904. doi: 10.1056/NEJMoa2118025. N Engl J Med. 2022. PMID: 36069871 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources